Findings on Hypogonadism Reported by Investigators at St. Jude Children's Research Hospital (Hypogonadism After Treatment for Medulloblastoma: Results From the Sjmb03 Trial of Risk-adapted Radiation Therapy).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      For more information on this research see: Hypogonadism After Treatment for Medulloblastoma: Results From the Sjmb03 Trial of Risk-adapted Radiation Therapy. Keywords: Memphis; State:Tennessee; United States; North and Central America; Brain; Cancer; Central Nervous System; Chemotherapy; Diencephalon; Drugs and Therapies; Endocrine System Diseases and Conditions; Gonadal Disorders; Health and Medicine; Hypogonadism; Hypothalamus; Limbic System; Medulloblastoma; Oncology; Pharmaceuticals; Radiation Therapy; Risk and Prevention; Surgery EN Memphis State:Tennessee United States North and Central America Brain Cancer Central Nervous System Chemotherapy Diencephalon Drugs and Therapies Endocrine System Diseases and Conditions Gonadal Disorders Health and Medicine Hypogonadism Hypothalamus Limbic System Medulloblastoma Oncology Pharmaceuticals Radiation Therapy Risk and Prevention Surgery 365 365 1 10/16/23 20231020 NES 231020 2023 OCT 16 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Research findings on Endocrine System Diseases and Conditions - Hypogonadism are discussed in a new report. [Extracted from the article]
    • Abstract:
      Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)